Skip to content

Breaking up Sedentary Time in Rheumatoid Arthritis

Breaking up Sedentary Time in Rheumatoid Arthritis: Effects on Vascular Function

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05284110
Enrollment
12
Registered
2022-03-17
Start date
2022-12-01
Completion date
2024-12-01
Last updated
2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Dysfunction, Rheumatoid Arthritis, Sedentary Behavior

Keywords

physical activity, rheumatic diseases, vascular function

Brief summary

This study will verify the effects of breaking up sitting time with short bouts of light intensity walking on vascular function in women with rheumatoid arthritis.

Detailed description

Women diagnosed with rheumatoid arthritis will participate in this randomized crossover trial. In one of the experimental sessions, the participants will remain 4-h on uninterrupted sitting, and in another day they will perform 3-min light intensity walk every 30 min to break up the sitting position. Vascular function will be assessed before and after each intervention using the following devices/techniques: a) transcranial Doppler ultrasound to assess the middle cerebral artery blood flow velocity at baseline and in response to CO2 breathing (5% CO2 mixture for 3 min), and to repeated sit-to-stand transitions; b) a multi-frequency linear transducer (7-12 MHz) attached to a high-resolution ultrasound machine to assess femoral artery dilation after reactive hyperemia (i.e., flow-mediated dilation); c) a laser Doppler probe attached to the skin surface of the right shin in order to quantify the Laser Doppler flux at baseline and during reactive hyperemia. Additionally, healthy age- and body mass-matched women will be recruited and will only perform the pre-intervention tests.

Interventions

BEHAVIORALPhysical activity

Multiple bouts of 3-min brisk walking, every 30 min, for 4 hours.

Sponsors

Liverpool University Hospitals NHS Foundation Trust
CollaboratorOTHER_GOV
Liverpool John Moores University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

The researcher who will perform the vascular analysis will be blinded to the allocation order.

Intervention model description

Participants with rheumatoid arthritis will attend the laboratory at Liverpool John Moores University on 2 occasions. During these visits, they will be submitted to the intervention or the control and will also undertake a series vascular tests prior- and post-intervention/control.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adult women diagnosed with RA * From the Rheumatology Clinic at the Liverpool University Hospitals NHS Foundation Trust * Aged 18-60 yr * Non-smoker for at least 6months * Able to provide written informed consent.

Exclusion criteria

* Cannot readily read and understand English. * Currently smoking or within last 6 months. * Alcohol consumption \>14units per week. * Symptoms of or established cardiovascular disease (except hypertension) * Previous stroke or myocardial infarction. * History of diabetes or respiratory disease or chronic kidney disease. * Musculoskeletal impairment/disability precluding physical activity * Unstable medication (change in medication within the 3 months) * Aged \<18 or \> 60 yr * Currently pregnant

Design outcomes

Primary

MeasureTime frameDescription
Middle cerebral artery mean velocity (MCAV)Change from baseline (hour 0) to hour 4 (post-intervention/control)MCAV will be assessed using continuous bilateral transcranial Doppler ultrasound.
Middle cerebral artery mean velocity reactivity to carbon dioxideChange from baseline (hour 0) to hour 4 (post-intervention/control)Participants will breathe a 5% carbon dioxide mixture for 3 min during which time MCAV reactivity to CO2 will be assessed using continuous bilateral transcranial Doppler ultrasound.
Cerebral autoregulationChange from baseline (hour 0) to hour 4 (post-intervention/control)Participants will be asked to complete a series of repeated sit to stand moves (coached by a member of the research team) for a 5-minute period, during which time MCAV will be assessed using continuous bilateral transcranial Doppler ultrasound. Beat by beat blood pressure will also be assessed using finger photoplethysmography.

Secondary

MeasureTime frameDescription
Skin blood flow response to hyperemiaChange from baseline (hour 0) to hour 4 (post-intervention/control)Skin blood flow response to hyperemia will be assessed using a laser doppler probe attached to the shin and forearm.
Stroop color-word testChange from baseline (hour 0) to hour 4 (post-intervention/control)The Stroop color-word test will be implemented to assess attention and inhibitory control.
California Verbal Learning Test-2Change from baseline (hour 0) to hour 4 (post-intervention/control)Immediate recall of the California Verbal Learning Test-2 will be used to assess verbal learning and memory.
Brachial artery endothelial functionChange from baseline (hour 0) to hour 4 (post-intervention/control)Brachial artery endothelial function will be assessed through flow-mediated dilation using vascular ultrasound.
Femoral artery blood flowChange from baseline to 1-hour/2-hour/3-hour/4-hourVascular ultrasound will be used to assess femoral artery blood flow every hour during the intervention
Pain intensityChange from baseline to 1-hour/2-hour/3-hour/4-hourPain intensity will be assessed using a 10cm visual analogue scale.
Brachial artery blood flowChange from baseline to 1-hour/2-hour/3-hour/4-hourVascular ultrasound will be used to assess brachial artery blood flow every hour during the intervention
Finger blood pressureChange from baseline (hour 0) to hour 4 (post-intervention/control)During all procedures, beat by beat finger blood pressure will be measured on the middle finger of the right hand using photoplethysmography.
Superficial femoral artery endothelial functionChange from baseline (hour 0) to hour 4 (post-intervention/control)Superficial femoral artery endothelial function will be assessed through flow-mediated dilation using vascular ultrasound.

Countries

United Kingdom

Contacts

Primary ContactDaniel Bannell, MPhil
D.J.Bannell@2015.ljmu.ac.uk07786008666
Backup ContactDavid Low, PhD
d.a.low@ljmu.ac.uk01519046244

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026